Examination of Unmet Treatment Needs Among Persons With Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

2013 ◽  
Vol 53 (8) ◽  
pp. 1300-1311 ◽  
Author(s):  
Richard B. Lipton ◽  
Dawn C. Buse ◽  
Daniel Serrano ◽  
Starr Holland ◽  
Michael L. Reed
Keyword(s):  
Episodic Migraine ◽  
Treatment Needs ◽  
Migraine Prevalence

Factors Associated With Triptan Use in Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study

2011 ◽  
Vol 52 (2) ◽  
pp. 213-223 ◽  
Author(s):  
Min Kyung Chu ◽  
Dawn C. Buse ◽  
Marcelo E. Bigal ◽  
Daniel Serrano ◽  
Richard B. Lipton
Keyword(s):  
Episodic Migraine ◽  
Prevention Study ◽  
Factors Associated ◽  
Migraine Prevalence

Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study

2013 ◽  
Vol 326 (1-2) ◽  
pp. 10-17 ◽  
Author(s):  
Starr Holland ◽  
Kristina M. Fanning ◽  
Daniel Serrano ◽  
Dawn C. Buse ◽  
Michael L. Reed ◽  
...  
Keyword(s):  
Episodic Migraine ◽  
Migraine Prevalence

Rates of Stressful Life Events in Chronic and Episodic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study (P04.240)

Neurology ◽  
2012 ◽  
Vol 78 (Meeting Abstracts 1) ◽  
pp. P04.240-P04.240
Author(s):  
A. Manack ◽  
D. Serrano ◽  
C. Turkel ◽  
R. Lipton ◽  
D. Buse
Keyword(s):  
Life Events ◽  
Stressful Life Events ◽  
Episodic Migraine ◽  
Stressful Life ◽  
Migraine Prevalence

Headache Impact of Chronic and Episodic Migraine: Results From the American Migraine Prevalence and Prevention Study

2011 ◽  
Vol 52 (1) ◽  
pp. 3-17 ◽  
Author(s):  
Dawn Buse ◽  
Aubrey Manack ◽  
Daniel Serrano ◽  
Michael Reed ◽  
Sepideh Varon ◽  
...  
Keyword(s):  
Episodic Migraine ◽  
Prevention Study ◽  
Migraine Prevalence ◽  
Headache Impact

Proposed new diagnostic criteria for chronic migraine

Cephalalgia ◽  
2019 ◽  
Vol 40 (4) ◽  
pp. 399-406 ◽  
Author(s):  
Mona Ameri Chalmer ◽  
Thomas Folkmann Hansen ◽  
Elena R Lebedeva ◽  
David W Dodick ◽  
Richard B Lipton ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Diagnostic Criteria ◽  
High Frequency ◽  
Treatment Options ◽  
Episodic Migraine ◽  
Treatment Needs ◽  
Cash Assistance ◽  
Number Of Patients ◽  
Definition Of ◽  
Significant Disease

Introduction ICHD-3 criteria for chronic migraine (CM) include a mixture of migraine and tension-type-like headaches and do not account for patients who have a high frequency of migraine but no other headaches. Materials and methods Patients from the Danish Headache Center and their relatives with ICHD-3 defined CM were compared with patients with high frequency episodic migraine (HFEM). Danish registries were used to compare the socioeconomic impact in these two groups. A Russian student population was used to determine the generalizability of the number of patients fulfilling CM and the proposed diagnostic criteria for CM. Results There was no difference in the demographic profile between the two groups in the Danish cohort. The number of lifelong or annual attacks ( p > 0.3), comorbid diseases, or self-reported effect of triptans ( p = 1) did not differ. HFEM patients purchased more triptans than CM patients ( p = 0.01). CM patients received more early pension ( p = 0.00135) but did not differ from HFEM patients with regard to sickness benefit ( p = 0.207), cash assistance ( p = 0.139), or rehabilitation benefit ( p = 1). Discussion Patients with HFEM are comparable to CM patients with regard to chronicity and disability. We therefore suggest classifying CM as ≥ 8 migraine days per month (proposed CM), disregarding the need for ≥ 15 headache days per month. The proposed diagnostic criteria for CM approximately doubled the number of patients with CM in both the Danish and the Russian materials. Extending the definition of CM to include patients with HFEM will ensure that patients with significant disease burden and unmet treatment needs are identified and provided appropriate access to the range of treatment options and resources available to those with CM. Conclusion Patients with migraine on eight or more days but not 15 days with headache a month are as disabled as patients with ICHD-3 defined CM. They should be included in revised diagnostic criteria for chronic migraine.

scholarly journals Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study

2013 ◽  
Vol 16 (1) ◽  
pp. 31-38 ◽  
Author(s):  
Daniel Serrano ◽  
Aubrey N. Manack ◽  
Michael L. Reed ◽  
Dawn C. Buse ◽  
Sepideh F. Varon ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Episodic Migraine ◽  
Migraine Prevalence ◽  
Productive Time
Sign in / Sign up

Export Citation Format

Share Document